Circulating tumor DNA in non-small-cell lung cancer: A step beyond blood

by Alfredo Addeo, Alex Friedlaender
Published 2020-01-01

Age is a fact and not an exclusion criterion in EGFR treatment

by Alex Friedlaender, Alfredo Addeo
Published 2020-01-01

First-line alectinib for ALK-positive lung cancer: is there room for further improvement?

by Alfredo Addeo, Giulio Metro
Published 2018-07-01

Intrathecal Methotrexate and Craniospinal Radiotherapy Can Be an Effective Treatment of Carcinomatous Meningitis in Patients with Breast Cancer: Case Reports

by Magdalena Meissner, Alfredo Addeo
Published 2016-10-01

Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient

by Alfredo Addeo, Ciro Roberto Rinaldi
Published 2013-05-01

Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic

by Alex Friedlaender, Chul Kim, Alfredo Addeo
Published 2020-05-01

New emerging targets in cancer immunotherapy: the role of TIM3

by Alex Friedlaender, Alfredo Addeo, Giuseppe Banna
Published 2019-06-01

KRAS G12C Mutations in NSCLC: From Target to Resistance

by Alfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender
Published 2021-05-01

Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer

by Solange Peters, Alex Friedlaender, Alfredo Addeo, Nuria Mederos
Published 2020-10-01

Reply to Authors

by Alex Friedlaender, Alfredo Addeo, Giuseppe Banna, Alessandra Curioni-Fontecedro
Published 2019-05-01

Vertebral Metastasis Treated by Vertebroplasty, a Cause of Respiratory Failure: Case Report and Literature Review

by Mathieu Chevallier, Chloé Chevallier-Lugon, Alex Friedlaender, Alfredo Addeo
Published 2021-03-01

How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere

by Alex Friedlaender, Alfredo Addeo, Giuseppe Banna, Alessandra Curioni-Fontecedro
Published 2019-05-01

Erratum to “A Case of Abdominal Sarcoidosis in a Patient with Acute Myeloid Leukemia”

by Vadsala Baskaran, Amanda Goodwin, Lavanya Athithan, Alfredo Addeo, Ciro Rinaldi
Published 2013-01-01

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?

by Alex Friedlaender, Giuseppe Banna, Umberto Malapelle, Pasquale Pisapia, Alfredo Addeo
Published 2019-03-01

Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-...

by Alfredo Addeo, Giuseppe Luigi Banna, Giulio Metro, Massimo Di Maio
Published 2019-04-01

Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review

by Laure Thouvenin, Timothée Olivier, Giuseppe Banna, Alfredo Addeo, Alex Friedlaender
Published 2021-03-01

A Case of Abdominal Sarcoidosis in a Patient with Acute Myeloid Leukemia

by Vadsala Baskaran, Amanda Goodwin, Lavanya Athithan, Ciro Roberto Rinaldi, Alfredo Addeo
Published 2013-01-01

The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy

by Alex Friedlaender, Petros Tsantoulis, Mathieu Chevallier, Claudio De Vito, Alfredo Addeo
Published 2021-03-01

Targeted Therapies in Early Stage NSCLC: Hype or Hope?

by Alex Friedlaender, Alfredo Addeo, Alessandro Russo, Vanesa Gregorc, Diego Cortinovis, Christian D. Rolfo
Published 2020-08-01

Tissue-Plasma TMB Comparison and Plasma TMB Monitoring in Patients With Metastatic Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors

by Alex Friedlaender, Thierry Nouspikel, Yann Christinat, Liza Ho, Thomas McKee, Alfredo Addeo
Published 2020-02-01